Alzheimer’s Association International Conference 2016
Cambridge Cognition will be demonstrating the latest neurotechnology at the Alzheimer's Association International Conference (AAIC) from July 22-23rd in Toronto, Canada. Our expert neuroscientists will present data using CANTAB for measuring change over time in MCI, as well as, how wearable devices could be used to measure cognition, mood and behaviour.
The team will be showcasing Cognition Kit™ and Cambridge Cognition's latest neurotechnology products enabling researchers, biotech and pharmaceutical companies to deliver success in clinical trials from patient recruitment and retention, through all phases of development and in post-marketing and patient engagement.
Join the team or a CANTAB researcher in one of the sessions below or find us on booth #823 to see the latest in neurotechnology from CANTAB.
|
Day |
Time |
Title |
Presenter |
# |
Type |
|---|---|---|---|---|---|
|
Saturday 23rd |
3:40 - 4:40 PM |
Commercialization of Technology Applications for Alzheimer’s Expert Panel
|
Francesca Cormack, PhD, Director of Research & Innovation
|
TD-P-017
|
Pre-conference |
|
Sunday 24th |
1:00 - 2:00 PM
|
Not Yet MCI: How to Detect Subtle Cognitive Impairment? |
Elena Chipi, University of Perugia, Italy |
P1-363
|
Poster |
|
Monday 25th |
1:00 - 2:00 PM |
Rosemary Abbott, PhD, Principal Statistical Analyst
|
P2-302
|
Poster |
|
|
Monday 25th |
1:00-2:00 PM |
Longitudinal Changes in Visual Memory in Mild Cognitive Impairment Versus Normal Aging in People with Subjective Cognitive Complains |
Onesimo Juncos-Rabadan, University of Santiago de Compostela |
P2-308 |
Poster |
|
Monday 25th |
2:00-2:15 PM
|
Cognitive Composite Measures in Amnestic MCI By Different Amyloid/Tau Pathology |
Marina Boccardi, IRCCS Istituto Centro San Giovanni di Dio-Fatebenefratelli, Brescia, Italy
|
O2-04-01
|
Oral |
|
Tuesday 26th |
9:30 - 10:30 AM |
Kenton Zavitz, PhD, Director of Clinical Affairs |
P3-011 |
Poster |
|
|
Tuesday 26th |
1:00 - 2:00 PM |
Rosemary Abbott, PhD, Principal Statistical Analyst |
P3-315 |
Poster |
|
|
Tuesday 26th |
2:00 - 3:30 PM |
Changes to Validity of Online Cognitive Assessment in Young and Older Adults: A Comparison to Supervised Testing Using the CANTAB Battery |
Francesca Cormack, PhD, Director of Research & Innovation |
O3-03-03
|
Oral |
Exhibit hall
On booth #823 Cambridge Cognition staff will be demonstrating the latest Cognitive Assessment Technology.
Product showcase
We will be premiering a number of cognitive assessment products for assessment of cognitive function from pre-symptomatic to mild to moderate Alzheimer's disease.
For pharmaceutical research
Designed to accelerate the recruitment process in clinical trials and reduce costly on-site screen failure.
Test batteries for Prodromal and Mild to Moderate Alzheimer’s disease to reliably assess cognition when developing treatments and interventions.
For academic research
Our Prodromal and Mild to Moderate Alzheimer’s batteries provide a rapid and reliably sensitive cognitive assessment system for developing treatments and interventions.
For healthcare
Daily tracking of patient health and wellbeing.
A short, sensitive iPad assessment of visuospatial episodic memory, functional status and mood to detect mild cognitive impairment in primary care and help doctors identify the earliest signs of Alzheimer’s disease.
Join us on booth #823 to find out more.
Meet our AAIC team
Myra Richley - Director of Pharmaceutical Business Development
Francesca Cormack, PhD, Director of Research & Innovation
Kenton Zavitz, PhD, Director Of Clinical Affairs
Rosemary Abbott, PhD, Principal Statistical Analyst
Deanna Friedrich - Sales Director
Anna Jackson - Healthcare Business Manager
Lizzie Remfry - Research & Biotech Business Manager
For more information on any of the above contact us now or join us at AAIC 2016 on booth #823.